Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ewout Landeloos
Observed names:
E. Landeloos,
Landeloos, Ewout
Institutions:
Universitair Ziekenhuis Leuven,
VIB-KU Leuven Center for Cancer Biology,
KU Leuven
Observed institutions:
Universitair Ziekenhuis Leuven,
VIB-KU Leuven Center for Cancer Biology,
Onze Lieve Vrouwziekenhuis Hospital,
VIB-KU Leuven Center for Microbiology,
KU Leuven
ORCID:
0000-0002-9128-6432
Observed ORCID:
0000-0002-9128-6432
OpenAlex ID:
A5047745885
A cellular hierarchy in melanoma uncouples growth and metastasis
2022
·
Panagiotis Karras
, Ignacio Bordeu
, et al.
·
Nature
·
274
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma
2024
·
Joanna Pozniak
, Dennis Pedri
, et al.
·
Cell
·
231
PDF
Epithelial‐to‐mesenchymal‐like transition events in melanoma
2021
·
Dennis Pedri
, Panagiotis Karras
, et al.
·
FEBS Journal
·
151
PDF
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
·
Cancer Discovery
·
44
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
2022
·
Sofía Ibáñez-Molero
, Alex van Vliet
, et al.
·
OncoImmunology
·
44
Itraconazole for COVID-19: Preclinical Studies and a Proof-of-Concept Pilot Clinical Study
2020
·
Laurens Liesenborghs
, Isabel Spriet
, et al.
·
EBioMedicine
·
38
PDF
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
2021
·
Ward Celus
, Ana I. Oliveira
, et al.
·
Cancer Immunology Research
·
29
PDF
A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma
2022
·
Joanna Pozniak
, Dennis Pedri
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
23
PDF
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
2020
·
T. Vanassche
, M. M. Engelen
, et al.
·
Trials
·
17
PDF
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
2021
·
Iwein Gyselinck
, Laurens Liesenborghs
, et al.
·
Trials
·
13
PDF
NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomas
2023
·
Ewout Landeloos
, Joanna Pozniak
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
Lactococcus garviae Prosthetic Mitral Valve Endocarditis: a Case Report and Literature Review
2017
·
Ewout Landeloos
, Guy Van Camp
, et al.
·
Clinical Microbiology Newsletter
·
3
Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”
2021
·
Laurens Liesenborghs
, Isabel Spriet
, et al.
·
EBioMedicine
·
2
PDF
Data from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
·
1
Author Correction: A cellular hierarchy in melanoma uncouples growth and metastasis
2022
·
Panagiotis Karras
, Ignacio Bordeu
, et al.
·
Nature
·
1
PDF
Supplemental Figures S1-S10 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Figure 2 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S10 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S12 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S1 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S3 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S13 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S9 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S11 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Supplemental Table S2 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
2025
·
Joanna Pozniak
, Niccolò Roda
, et al.
Show more works
View as search
Works count:
46
Citation count:
875
H-index:
10
I10-index:
10
Year
Topic
Type